The report provides a detailed analysis essential for establishing a cephradine production plant. It encompasses all critical aspects necessary for cephradine production, including the cost of cephradine production, cephradine plant cost, cephradine production costs, and the overall cephradine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a cephradine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Cephradine is a first-generation cephalosporin antibiotic that effectively treats various bacterial infections. It is primarily utilised for respiratory tract infections like pharyngitis, tonsillitis, bronchitis, and pneumonia caused by susceptible strains of bacteria, including staphylococci and streptococci. It finds its main application in managing ear infections such as otitis media, urinary tract conditions including cystitis and pyelonephritis, and skin issues like cellulitis, abscesses, and impetigo. Moreover, it is often used as a preventive measure in surgical procedures to reduce the risk of postoperative infections. It also finds its application in veterinary medicine for treating infections in livestock and pets. It also helps in treating bone infections and uncomplicated genitourinary disorders. Additionally, it is also used in pharmaceutical formulations and research to develop new antibacterial therapies and improve existing treatment options.
The primary factor that drives the market for cephradine is its demand as an antibiotic for the treatment of bacterial infections affecting the respiratory tract, skin, urinary tract, and bones. Its application as a drug in the treatment of tonsillitis, bronchitis, pharyngitis, and ear infections largely promotes its demand in the medical and pharmaceutical industries. Its usage as an important option for perioperative prophylaxis in surgeries and certain soft tissue infections also contributes to its demand in the medical and healthcare sectors.
Its demand as an important antibiotic in both human and veterinary healthcare for treating infections caused by susceptible gram-positive and some gram-negative bacteria also boosts its market growth. In addition, industrial cephradine procurement is shaped by several factors such as the cost and availability of raw materials, compliance with pharmaceutical regulations, and adherence to quality and environmental standards. Moreover, improvements in production processes, reliable supplier networks, sustainable production practices, and efficient logistics systems play an important role in influencing its procurement decisions and overall market development.
Raw Material for Cephradine Production
According to the cephradine production plant project report, the major raw materials for cephradine production include phenylglycine, lithium, liquid ammonia, methyl acetoacetate, ethyl chloroformate, triethylamine, and deacetylated 7-aminocephalosporanic acid.
Production Process of Cephradine
The extensive cephradine production cost report consists of the following industrial production process:
- Production from Phenylglycine: The production process of cephradine begins with partially reducing phenylglycine using lithium in liquid ammonia to form 1,4-cyclohexadienylglycine, where the phenyl ring gets hydrated into a cyclohexadienyl moiety. Then, the amino group on this compound is protected by reacting it with methyl acetoacetate in the presence of sodium methoxide, creating a stable salt. Further, this protected intermediate is converted into a mixed anhydride using ethyl chloroformate and triethylamine, which is then coupled with deacetylated 7-aminocephalosporanic acid to acylate the core. The complete process results in the formation of cephradine as the final broad-spectrum cephalosporin antibiotic.
Cephradine is a first-generation semi-synthetic cephalosporin antibiotic that acts by inhibiting bacterial cell wall synthesis through interference with the transpeptidase enzyme. It appears as a white to light yellow crystalline powder. The molecular formula of the compound is C16H19N3O4S, and its molar mass is 349.40 g/mol. It is a zwitterion containing both an alkaline amino group and an acidic carboxyl group, which makes it freely soluble in water and aqueous solvents. The melting point of the compound is around 140 degree Celsius, and its boiling point is around 898 degree Celsius. The compound is stable to acid and is almost completely absorbed after oral administration. Hypersensitivity reactions occur in approximately 5% or less of patients receiving cephradine, including urticaria, pruritus, rash, fever, eosinophilia, and, in rare cases, anaphylaxis and Stevens-Johnson Syndrome. It is contraindicated in patients with a history of allergic reactions to cephalosporin antibiotics and should be used with caution in patients allergic to penicillins. It is recommended to store the compound at room temperature away from moisture and heat.